earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke
Launched by RENNES UNIVERSITY HOSPITAL · May 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people recover movement in their arms after a stroke. Specifically, the researchers want to see if a treatment called electroencephalographic neurofeedback, combined with traditional rehabilitation exercises, can improve upper limb function. They will compare this approach to a control group receiving traditional rehab along with a fake version of the neurofeedback treatment.
To participate in this study, individuals should be adults aged 18 to 80 who have had a stroke within the last three weeks and have specific difficulties using their arm. They need to be able to understand the study information and provide consent (or have a family member help if necessary). Participants can expect to engage in both the new neurofeedback treatment and standard rehabilitation exercises to help regain arm movement. It's important to note that certain conditions, like having a brain injury in specific areas or significant communication challenges, may exclude someone from joining the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral ischaemic or haemorrhagic stroke
- • Adult (18-80 years), both sexes
- • Stroke \< 3 weeks
- • Upper limb deficit defined by Shoulder Abduction Finger Extension score \<5 on day 3 of stroke; i.e., patients predicted to have incomplete recovery
- • No participation-limiting comprehension problems
- • With or without homonymous lateral hemianopia; with or without visuospatial hemineglect
- • Free, informed and written consent signed by the patient or a member of the patient's family (in the case of a patient who is able to understand the information and give consent but has motor difficulties resulting in an invalid signature).
- • Affiliated to french social security
- Exclusion Criteria:
- • Ischemic or hemorrhagic brain stem and/or cerebellum involvement
- • Multiple strokes
- • Stroke \< 1 week; in order not to be deleterious by starting active rehabilitation too early after immediate stroke
- • Aphasia with major comprehension impairment
- • Contraindication to MRI
- • pacemaker or implantable defibrillator,
- • neurosurgical clips,
- • cochlear implants,
- • intra-orbital or encephalic metallic foreign bodies,
- • stents placed less than 4 weeks ago and osteosynthesis devices placed less than 6 weeks ago,
- • claustrophobia.
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Patients applied
Trial Officials
Simon BUTET, MD
Principal Investigator
Rennes CHU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported